Cargando…

Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System

Cancer immunotherapy has revolutionized the oncology field, but many patients still do not respond to current immunotherapy approaches. One of the main challenges in broadening the range of responses to this type of treatment is the limited source of tumor neoantigens. T cells constitute a main line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meraviglia-Crivelli, Daniel, Zheleva, Angelina, Barainka, Martin, Moreno, Beatriz, Villanueva, Helena, Pastor, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405394/ https://www.ncbi.nlm.nih.gov/pubmed/36009389 http://dx.doi.org/10.3390/biomedicines10081842

Ejemplares similares

A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
por: Meraviglia-Crivelli, Daniel, et al.
Publicado: (2022)

Modulating T Cell Responses by Targeting CD3
por: Menon, Ashwathi Puravankara, et al.
Publicado: (2023)

IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
por: Meraviglia-Crivelli, Daniel, et al.
Publicado: (2022)

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019)

Aptamer-iRNAs as Therapeutics for Cancer Treatment
por: Soldevilla, Mario M., et al.
Publicado: (2018)

Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
por: Sola, Mayte, et al.
Publicado: (2020)

Oligonucleotide-Based Therapies for Renal Diseases
por: Cartón-García, Fernando, et al.
Publicado: (2021)

Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment
por: Zhu, Guidong, et al.
Publicado: (2021)

DCision-making in tumors governs T cell anti-tumor immunity
por: Alfei, Francesca, et al.
Publicado: (2021)

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment
por: Hendry, Shona A., et al.
Publicado: (2016)

Peptide intra-tumor injection for cancer immunotherapy: Enhancement of tumor cell antigenicity is a novel and attractive strategy
por: Nobuoka, Daisuke, et al.
Publicado: (2013)

Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells()
por: Betting, David J., et al.
Publicado: (2009)

Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment
por: Lo Presti, Elena, et al.
Publicado: (2014)

Therapeutic Antibodies against Intracellular Tumor Antigens
por: Trenevska, Iva, et al.
Publicado: (2017)

The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies
por: Wang, Danting, et al.
Publicado: (2022)

Polyamine Depletion Strategies in Cancer: Remodeling the Tumor Immune Microenvironment to Enhance Anti-Tumor Responses
por: Chin, Alexander, et al.
Publicado: (2022)

Tumor Associated Antigens and Their Specific Immune Response
por: Vose, B. M.
Publicado: (1980)

The Origin and Immune Recognition of Tumor-Specific Antigens
por: Apavaloaei, Anca, et al.
Publicado: (2020)

Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
por: Anfray, Clément, et al.
Publicado: (2019)

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens
Publicado: (1975)

Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies
por: Bryant, Jean-Paul, et al.
Publicado: (2021)

Magnetic nanoparticles enhance the cellular immune response of dendritic cell tumor vaccines by realizing the cytoplasmic delivery of tumor antigens
por: Huang, Linghong, et al.
Publicado: (2022)

Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens
por: Darrigrand, Romain, et al.
Publicado: (2021)

High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
por: Willebrand, Ralf, et al.
Publicado: (2019)

Anti-angiogenesis: making the tumor vulnerable to the immune system
por: Griffioen, Arjan W.
Publicado: (2008)

Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination
por: Schreiber, Taylor H., et al.
Publicado: (2012)

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot
por: Ullman, Nicholas A., et al.
Publicado: (2022)

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma
por: von Felden, Johann, et al.
Publicado: (2018)

Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2021)

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018)

Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer
por: Lu, Guangrong, et al.
Publicado: (2020)

The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
por: Zhang, Zhengjia, et al.
Publicado: (2022)

RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in Melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022)

Blocking HIF to Enhance NK Cells: Hints for New Anti-Tumor Therapeutic Strategies?
por: Vitale, Massimo, et al.
Publicado: (2021)

Antigen shedding into the circulation contributes to tumor immune escape
por: Höchst, Bastian, et al.
Publicado: (2012)

Peroxynitrite promotes immune evasion by reducing tumor antigenicity
por: Capietto, Aude-Hélène, et al.
Publicado: (2022)

Therapeutic Anti-Tumor Vaccines: From Tumor Inhibition to Enhancement
por: Chiarella, Paula, et al.
Publicado: (2008)

Therapeutic strategies to remodel immunologically cold tumors
por: Wang, Minyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r9ov802c0qterni965qdka9c9g